跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
APO-WARFARIN 5MG TABLET - HSA Drug Approval Details
Approvals
/
HSA
/
APO-WARFARIN 5MG TABLET
Approved
THERAPEUTIC
APO-WARFARIN 5MG TABLET
APOTEX INC. (CANADA)
🇸🇬 Health Sciences Authority
Approval Date
Aug 12, 2008
Approval ID
a36a1ab78a563231
Company
APOTEX INC. (CANADA)
Type
Therapeutic
Approval Details
Approval Id
a36a1ab78a563231
Drug Name
APO-WARFARIN 5MG TABLET
Product Name
APO-WARFARIN 5MG TABLET
Approval Number
SIN13517P
Approval Date
2008-08-12
Registrant
PHARMAFORTE SINGAPORE PTE LTD
Licence Holder
PHARMAFORTE SINGAPORE PTE LTD
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
TABLET
Route Of Administration
ORAL
Atc Code
B01AA03
Atc Item Name
warfarin
Pharma Manufacturer Name
PHARMAFORTE SINGAPORE PTE LTD
Active Ingredients
Warfarin (as warfarin sodium 92% 5.59mg)
5 mg
WARFARIN (AS WARFARIN SODIUM 92% 5.59 MG)
5 MG
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Aug 12, 2008
Approval ID
a36a1ab78a563231
Type
Therapeutic
Back to HSA Approvals